| abstract |
A polypeptide, for use as a pharmaceutical, comprising: a) an amino acid sequence, comprising one or more surface exposed fragments of the same outer membrane protein expressed in a Chlamydia sp serotype; and b) two or more additional amino acid sequences that are either the same sequence as defined in a) or that are the surface exposed fragments corresponding to a variant of said outer membrane protein expressed in a Chlamydia sp serotype. , which is different from the serotype in a); wherein the outer membrane protein is MOMP of any serotype and wherein the polypeptide comprises one or more of the variable domains 1, 2, 3, 4 of MOMP. |